Causaly develops AI technology for Biomedical Cause & Effect Discovery, empowering researchers and decision makers to quickly find causal evidence and generate insights from vast amounts of documents.
The company is developing a machine-reading platform comprised of a variety of Natural Language Processing and Computational Linguistics algorithms among which are information and relationship extraction, entity linking, knowledge inference and relational learning, abbreviation and coreference resolution. The platform turns free-flow text into causal knowledge graphs and applies machine learning to surface new knowledge.
Causaly is aiming to transform the way researchers interact with information, facilitating a shift from keyword and Boolean search in literature reviews to semantic search and immediate surfacing of answers from across tens of millions of documents.
The company is based in the UK (London) and Greece (Athens).